Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Afriplex is a leading South African company specializing in the development and manufacture of premium botanical extracts and natural product solutions for the pharmaceutical, nutraceutical, and food and beverage industries. Established in 2001, the company provides a comprehensive range of services including raw material sourcing, extraction, product formulation, and large-scale GMP manufacturing. Afriplex is globally recognized for its expertise in indigenous African flora, such as Rooibos, Pelargonium sidoides, and Sceletium tortuosum. The company operates state-of-the-art facilities in Paarl, South Africa, and holds a medicinal cannabis license, positioning it as a key player in the global natural health products market. Their business model combines contract manufacturing (CDMO) with the supply of proprietary active pharmaceutical ingredients (APIs) derived from nature.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Afriplex.